These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11378213)

  • 41. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type 1 1/2 diabetes: myth or reality?
    Juneja R; Palmer JP
    Autoimmunity; 1999; 29(1):65-83. PubMed ID: 10052687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
    Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
    Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of autoimmune type 1 diabetes and multiple organ-specific autoantibodies in adult-onset non-insulin-requiring diabetes in China: A population-based multicentre nationwide survey.
    Xiang Y; Huang G; Zhu Y; Zuo X; Liu X; Feng Q; Li X; Yang T; Lu J; Shan Z; Liu J; Tian H; Ji Q; Zhu D; Ge J; Lin L; Chen L; Guo X; Zhao Z; Li Q; Weng J; Jia W; Liu Z; Ji L; Yang W; Leslie RD; Zhou Z;
    Diabetes Obes Metab; 2019 Apr; 21(4):893-902. PubMed ID: 30471182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults.
    Yang L; Zhou ZG; Tan SZ; Huang G; Jin P; Yan X; Li X; Peng H; Hagopian W
    Ann N Y Acad Sci; 2008 Dec; 1150():263-6. PubMed ID: 19120309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
    Verge CF; Stenger D; Bonifacio E; Colman PG; Pilcher C; Bingley PJ; Eisenbarth GS
    Diabetes; 1998 Dec; 47(12):1857-66. PubMed ID: 9836516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.
    Xiang Y; Huang G; Shan Z; Pan L; Luo S; Yang L; Shi L; Li Q; Leslie RD; Zhou Z
    Acta Diabetol; 2015 Dec; 52(6):1121-7. PubMed ID: 26239144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-GAD65 autoantibody in Taiwanese patients with insulin-dependent diabetes mellitus: effect of HLA on anti-GAD65 positivity and clinical characteristics.
    Chuang LM; Lin CY; Wu HP; Tsai WY; Tai TY; Lin BJ
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):455-61. PubMed ID: 9404444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies.
    Rattarasarn C; Diosdado MA; Ortego J; Leelawattana R; Soonthornpun S; Setasuban W; Jaruratanasirikul S; Patarakijvanich N
    Diabetes Res Clin Pract; 2000 Aug; 49(2-3):107-11. PubMed ID: 10963821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
    Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
    J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients.
    Pardini VC; Mourao DM; Nascimento PD; Vívolo MA; Ferreira SR; Pardini H
    Braz J Med Biol Res; 1999 Oct; 32(10):1195-8. PubMed ID: 10510254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes.
    McDonald TJ; Colclough K; Brown R; Shields B; Shepherd M; Bingley P; Williams A; Hattersley AT; Ellard S
    Diabet Med; 2011 Sep; 28(9):1028-33. PubMed ID: 21395678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative analysis of organ-specific autoantibodies and celiac disease--associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects.
    Jaeger C; Hatziagelaki E; Petzoldt R; Bretzel RG
    Diabetes Care; 2001 Jan; 24(1):27-32. PubMed ID: 11194235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.
    Steck AK; Johnson K; Barriga KJ; Miao D; Yu L; Hutton JC; Eisenbarth GS; Rewers MJ
    Diabetes Care; 2011 Jun; 34(6):1397-9. PubMed ID: 21562325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationships among 64k autoantibodies, pancreatic beta-cell function, HLA-DR antigens and HLA-DQ genes in patients with insulin-dependent diabetes mellitus in Korea.
    Lee HC; Cha BS; Nam MS; Song YD; Lim SK; Kim DH; Huh KB; Koh Y
    Korean J Intern Med; 1995 Jan; 10(1):1-9. PubMed ID: 7626550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.
    Decochez K; Tits J; Coolens JL; Van Gaal L; Krzentowski G; Winnock F; Anckaert E; Weets I; Pipeleers DG; Gorus FK
    Diabetes Care; 2000 Jun; 23(6):838-44. PubMed ID: 10841006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients.
    Liu J; Bian L; Ji L; Chen Y; Chen H; Gu Y; Ma B; Gu W; Xu X; Shi Y; Wang J; Zhu D; Sun Z; Ma J; Jin H; Shi X; Miao H; Xin B; Zhu Y; Zhang Z; Bu R; Xu L; Shi G; Tang W; Li W; Zhou D; Liang J; Cheng X; Shi B; Dong J; Hu J; Fang C; Zhong S; Yu W; Lu W; Wu C; Qian L; Yu J; Gao J; Fei X; Zhang Q; Wang X; Cui S; Cheng J; Xu N; Wang G; Han G; Xu C; Xie Y; An M; Zhang W; Wang Z; Cai Y; Fu Q; Fu Y; Zheng S; Yang F; Hu Q; Dai H; Jin Y; Zhang Z; Xu K; Li Y; Shen J; Zhou H; He W; Zheng X; Han X; Yu L; She J; Zhang M; Yang T
    Sci China Life Sci; 2016 Sep; 59(9):930-9. PubMed ID: 27225179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.